. | Age 3–17 y . | Age 6–35 mo . | ||
---|---|---|---|---|
. | QIV (N = 932) . | TIV-Vic (N = 929) . | TIV-Yam (N = 932) . | QIV (N = 301) . |
Mean age in years (SD; median; range) | 8.9 (4.21; 8.0; 3–17) | 8.9 (4.23; 9.0; 2–17) | 8.9 (4.17; 9.0; 3–17) | 1.2 (0.73; 1.0; 0–2) |
Mean age in months (SD; median; range) | 112.4 (51.06; 107.0; 36–215) | 111.8 (51.10; 108.0; 34–215) | 111.8 (50.08; 108.5; 36–215) | 21.0 (8.68; 21.0; 6–35) |
Male, n (%) | 498 (53.4) | 474 (51.0) | 468 (50.2) | 158 (52.5) |
Female, n (%) | 434 (46.6) | 455 (49.0) | 464 (49.8) | 143 (47.5) |
Hispanic/Latino ethnicity | 235 (25.2) | 235 (25.3) | 245 (26.3) | 56 (18.6) |
Not Hispanic/Latino ethnicity | 697 (74.8) | 694 (74.7) | 687 (73.7) | 245 (81.4) |
Heritage/race | ||||
European heritage/Caucasian | 598 (64.2) | 580 (62.4) | 575 (61.7) | 206 (68.4) |
Asian | 119 (12.8) | 125 (13.6) | 125 (13.4) | 18 (5.9) |
African heritage/African American | 83 (8.9) | 85 (9.1) | 87 (9.3) | 48 (15.9) |
American Indian/native Alaskan | 6 (0.6) | 1 (0.1) | 1 (0.1) | 6 (2.0) |
Pacific Islander/native Hawaiian | 3 (0.3) | 1 (0.1) | 4 (0.4) | 0 |
Other | 123 (13.2) | 137 (14.7) | 140 (15.0) | 23 (7.6) |
. | Age 3–17 y . | Age 6–35 mo . | ||
---|---|---|---|---|
. | QIV (N = 932) . | TIV-Vic (N = 929) . | TIV-Yam (N = 932) . | QIV (N = 301) . |
Mean age in years (SD; median; range) | 8.9 (4.21; 8.0; 3–17) | 8.9 (4.23; 9.0; 2–17) | 8.9 (4.17; 9.0; 3–17) | 1.2 (0.73; 1.0; 0–2) |
Mean age in months (SD; median; range) | 112.4 (51.06; 107.0; 36–215) | 111.8 (51.10; 108.0; 34–215) | 111.8 (50.08; 108.5; 36–215) | 21.0 (8.68; 21.0; 6–35) |
Male, n (%) | 498 (53.4) | 474 (51.0) | 468 (50.2) | 158 (52.5) |
Female, n (%) | 434 (46.6) | 455 (49.0) | 464 (49.8) | 143 (47.5) |
Hispanic/Latino ethnicity | 235 (25.2) | 235 (25.3) | 245 (26.3) | 56 (18.6) |
Not Hispanic/Latino ethnicity | 697 (74.8) | 694 (74.7) | 687 (73.7) | 245 (81.4) |
Heritage/race | ||||
European heritage/Caucasian | 598 (64.2) | 580 (62.4) | 575 (61.7) | 206 (68.4) |
Asian | 119 (12.8) | 125 (13.6) | 125 (13.4) | 18 (5.9) |
African heritage/African American | 83 (8.9) | 85 (9.1) | 87 (9.3) | 48 (15.9) |
American Indian/native Alaskan | 6 (0.6) | 1 (0.1) | 1 (0.1) | 6 (2.0) |
Pacific Islander/native Hawaiian | 3 (0.3) | 1 (0.1) | 4 (0.4) | 0 |
Other | 123 (13.2) | 137 (14.7) | 140 (15.0) | 23 (7.6) |
Abbreviations: QIV, quadrivalent influenza vaccine; SD, standard deviation; TIV-Vic, trivalent influenza vaccine Victoria lineage B strain; TIV-Yam, trivalent influenza vaccine Yamagata lineage B strain.
. | Age 3–17 y . | Age 6–35 mo . | ||
---|---|---|---|---|
. | QIV (N = 932) . | TIV-Vic (N = 929) . | TIV-Yam (N = 932) . | QIV (N = 301) . |
Mean age in years (SD; median; range) | 8.9 (4.21; 8.0; 3–17) | 8.9 (4.23; 9.0; 2–17) | 8.9 (4.17; 9.0; 3–17) | 1.2 (0.73; 1.0; 0–2) |
Mean age in months (SD; median; range) | 112.4 (51.06; 107.0; 36–215) | 111.8 (51.10; 108.0; 34–215) | 111.8 (50.08; 108.5; 36–215) | 21.0 (8.68; 21.0; 6–35) |
Male, n (%) | 498 (53.4) | 474 (51.0) | 468 (50.2) | 158 (52.5) |
Female, n (%) | 434 (46.6) | 455 (49.0) | 464 (49.8) | 143 (47.5) |
Hispanic/Latino ethnicity | 235 (25.2) | 235 (25.3) | 245 (26.3) | 56 (18.6) |
Not Hispanic/Latino ethnicity | 697 (74.8) | 694 (74.7) | 687 (73.7) | 245 (81.4) |
Heritage/race | ||||
European heritage/Caucasian | 598 (64.2) | 580 (62.4) | 575 (61.7) | 206 (68.4) |
Asian | 119 (12.8) | 125 (13.6) | 125 (13.4) | 18 (5.9) |
African heritage/African American | 83 (8.9) | 85 (9.1) | 87 (9.3) | 48 (15.9) |
American Indian/native Alaskan | 6 (0.6) | 1 (0.1) | 1 (0.1) | 6 (2.0) |
Pacific Islander/native Hawaiian | 3 (0.3) | 1 (0.1) | 4 (0.4) | 0 |
Other | 123 (13.2) | 137 (14.7) | 140 (15.0) | 23 (7.6) |
. | Age 3–17 y . | Age 6–35 mo . | ||
---|---|---|---|---|
. | QIV (N = 932) . | TIV-Vic (N = 929) . | TIV-Yam (N = 932) . | QIV (N = 301) . |
Mean age in years (SD; median; range) | 8.9 (4.21; 8.0; 3–17) | 8.9 (4.23; 9.0; 2–17) | 8.9 (4.17; 9.0; 3–17) | 1.2 (0.73; 1.0; 0–2) |
Mean age in months (SD; median; range) | 112.4 (51.06; 107.0; 36–215) | 111.8 (51.10; 108.0; 34–215) | 111.8 (50.08; 108.5; 36–215) | 21.0 (8.68; 21.0; 6–35) |
Male, n (%) | 498 (53.4) | 474 (51.0) | 468 (50.2) | 158 (52.5) |
Female, n (%) | 434 (46.6) | 455 (49.0) | 464 (49.8) | 143 (47.5) |
Hispanic/Latino ethnicity | 235 (25.2) | 235 (25.3) | 245 (26.3) | 56 (18.6) |
Not Hispanic/Latino ethnicity | 697 (74.8) | 694 (74.7) | 687 (73.7) | 245 (81.4) |
Heritage/race | ||||
European heritage/Caucasian | 598 (64.2) | 580 (62.4) | 575 (61.7) | 206 (68.4) |
Asian | 119 (12.8) | 125 (13.6) | 125 (13.4) | 18 (5.9) |
African heritage/African American | 83 (8.9) | 85 (9.1) | 87 (9.3) | 48 (15.9) |
American Indian/native Alaskan | 6 (0.6) | 1 (0.1) | 1 (0.1) | 6 (2.0) |
Pacific Islander/native Hawaiian | 3 (0.3) | 1 (0.1) | 4 (0.4) | 0 |
Other | 123 (13.2) | 137 (14.7) | 140 (15.0) | 23 (7.6) |
Abbreviations: QIV, quadrivalent influenza vaccine; SD, standard deviation; TIV-Vic, trivalent influenza vaccine Victoria lineage B strain; TIV-Yam, trivalent influenza vaccine Yamagata lineage B strain.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.